Loperamide: Difference between revisions
3amrbadawy (talk | contribs) (lop moa) |
3amrbadawy (talk | contribs) (lop ref) |
||
| Line 78: | Line 78: | ||
<references/> | <references/> | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
*[https://online.epocrates.com/drugs/181310/Imodium/Monograph Epocrates: Loperamide] | |||
Revision as of 19:26, 25 January 2016
Administration
- Type:
- Dosage Forms:
- Routes of Administration:
- Common Trade Names: Imodium
Adult Dosing
- Acute Diarrhea:
- 2 mg PO per dose
- Start: 4 mg PO x1, then 2 mg PO after each loose stool; Max: 16 mg/day
- 2 mg PO per dose
- Chronic Diarrhea
- 4-8 mg/day PO divided qd-tid
- Start: 4 mg PO x1, then 2 mg PO after each loose stool until maint. dose established; Max: 16 mg/day
- 4-8 mg/day PO divided qd-tid
Pediatric Dosing
- Acute diarrhea:
- 2-5 yo, 13-20 kg
- Dose: 1 mg PO x1 after each loose stool
- Max: 3 mg/day
- Use OTC 1 mg/5 sol or 1 mg/7.5 mL susp
- Dose: 1 mg PO x1 after each loose stool
- 6-8 yo, 20-30 kg
- Dose: start 2 mg PO x1, then 1 mg PO after each loose stool
- Max: 4 mg/day
- Dose: start 2 mg PO x1, then 1 mg PO after each loose stool
- 8-11 yo, 30-40 kg
- Dose: start 2 mg PO x1, then 1 mg PO after each loose stool
- Max: 6 mg/day
- Dose: start 2 mg PO x1, then 1 mg PO after each loose stool
- 12 yo and older
- Dose: start 4 mg PO x1, then 2 mg PO after each loose stool
- Max: 8 mg/day
- Dose: start 4 mg PO x1, then 2 mg PO after each loose stool
- 2-5 yo, 13-20 kg
- Chronic diarrhea
- 0.08-0.24 mg/kg/day PO divided bid-tid
- Max: 2 mg/dose
- 0.08-0.24 mg/kg/day PO divided bid-tid
Special Populations
- Pregnancy Rating: B
- Lactation risk: Probably safe
Renal Dosing
- Adult:
Hepatic Dosing
- Adult/Pediatric: Reduced first-pass metabolism
- CNS toxicity
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- toxic megacolon
- paralytic ileus
- angioedema
- anaphylaxis/anaphylactoid rxn
- toxic epidermal necrolysis
- Stevens-Johnson syndrome
- erythema multiforme
- urinary retention
- heat stroke
Common
- constipation
- nausea
- abdominal cramps
- dizziness
Pharmacology
- Half-life: Half-life: 10.8h
- Metabolism: liver; CYP450: 2C8, 3A4 substrate; Info: P-gp substrate; 40% systemic absorption
- Excretion: feces 30%, urine <2%
Mechanism of Action
binds gut wall opioid receptor, inhibiting peristalsis; increases anal sphinctor tone
